Refreshed content for CJC-1295ai_activityai-researcherApr 16, 2026
Pulled 4 linked studies for context. - **content** updated: Body content rewritten (+380 chars; was 1034, now 1414).
No external link
GHRH analogue used in research contexts for GH/IGF-1 modulation, muscle and bone density, sleep, and recovery.
Community effect votes, structured logs, and side-effect summaries.
Effect profile (overview)
Aggregate AI baseline blended with community voting. Hover to inspect effect strengths per category.
Effect scores blend an AI baseline with community votes. Open the full chart to see sliders and vote on each category.
Research log summary heatmap
Compact view of how logs describe shifts in pain, sleep, and performance (−5 to +5). Treat this as qualitative, anonymous signal only.
No community research logs yet. When structured logs are added, this panel will summarize typical shifts in pain, sleep, and performance.
Anonymous side-effect patterns
Rough heatmap of anonymous side-effect and positive-signal tags — a "most-mentioned" snapshot, not safety or efficacy advice.
No anonymous side-effect reports yet. When reports are submitted, this panel will show a simple heatmap of tags like "nausea", "flushing", "improved healing", and more.
Research footprint
Last analyzed Apr 17, 20266
Studies indexed
0
Human
0
Animal
5
AI analyzed
Evidence mix0% human · 0% animal · 0% cellular · 0% review
Highest phase: Preclinical onlyYears covered: 2026
Librarian pulse — latest actionsFull changelog ↓
- Apr 16, 5:13 PMRefreshedRefreshed content for CJC-1295
- Apr 16, 5:13 PMRefreshedRefreshed content for CJC-1295
Research & intelligence feed
Studies, clinical trials, community discussions, and news.
Refreshed content for CJC-1295ai_activityai-researcherApr 16, 2026
Pulled 4 linked studies for context. - **content** updated: Body content rewritten (+187 chars; was 1034, now 1221).
No external link
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Phase 2 Study to Evaluate the Efficacy and Safety of CJC 1295 Administered for 12 Weeks in HIV Infected Patients With HIV Associated Visceral ObesityClinical TrialClinicalTrials.govApr 16, 2026
This study evaluated the efficacy and safety of CJC-1295 in HIV-infected patients with HIV-associated visceral obesity over 12 weeks. The study involved a randomized, placebo-controlled design. No therapeutic claims are made.
Phase: PHASE2Status: TERMINATED
Semantic Scholar search for CJC-1295StudySemanticScholarDec 12, 2025
Cationic exchange SPE combined with triple quadrupole UHPLC-MS/MS for detection of GHRHs in urine samples.StudyPubMedDec 12, 2025
Not reported in abstract.
Chromatographic-mass spectrometric analysis of peptidic analytes (2-10 kDa) in doping control urine samples.StudyPubMedDec 12, 2025
Not reported in abstract.
Analysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography coupled with quadrupole/orbitrap mass spectrometry.StudyPubMedDec 12, 2025
Not reported in abstract.
External databases
Helpful external resources for additional structural, pharmacologic, and literature context. These are third-party databases; always cross-check details with primary research.
Community notes
No comments yet. Share research notes, citations, or observations below.
Community research logs (detail)
No community research logs yet. Use the “Contribute data” button above to share an anonymized summary of your experience.
Anonymous side-effect reporting (detail)
This section describes how anonymous side-effect reports are aggregated into the heatmap above. Reports are anonymous and unverified, and should be read alongside primary safety data.
Use the "Report side effects" button to open a focused popup form. Please keep descriptions neutral and avoid medical language; think in terms of "nausea", "flushing", "vivid dreams", etc.
Librarian Changelog
Every time the Librarian touches this peptide — discovering, refreshing, scoring, or verifying — it logs the action here.
1d agoRefreshai-researcher85%
Refreshed content for CJC-1295
1d agoRefreshai-researcher85%
Refreshed content for CJC-1295